American Gene Technologies
Latest round
- Series B
Last raised
- Jan 2025
Total raised
- $25M
Investors
- 1
About American Gene Technologies
Founded in 2007 and based in Maryland, US, American Gene Technologies Inc. operates as a clinical-stage biotechnology company that provides gene and cell therapy for diseases like cancer and the human immunodeficiency virus (HIV). As of 2022, Jeff Galvin is the founder and CEO of the company. In April 2022, American Gene Technologies, Inc. The company is developing genetic therapies to treat significant diseases such as HIV, PKU, and hepatocellular carcinoma (also known as liver cancer, or HCC). The company offers the American Gene™ delivery platform, which speeds up the development of a wide range of medication candidates. The company's pipeline includes AGT-103-T, an HIV treatment in Phase 1 clinical trials, and AGT-CS168, which collects venous blood specimens from HIV patients. American Gene's technology includes drug development, genetic technology, and immunotox - gamma delta T cell cancer therapy.
Who invested in American Gene Technologies
1 investor across 2 rounds
See all investors in American Gene Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about American Gene Technologies
Who invested in American Gene Technologies?
American Gene Technologies has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has American Gene Technologies raised?
American Gene Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did American Gene Technologies last raise money?
American Gene Technologies's most recent round on record is a Series B, in Jan 2025.
What does American Gene Technologies do?
Founded in 2007 and based in Maryland, US, American Gene Technologies Inc.
Where is American Gene Technologies headquartered?
American Gene Technologies is headquartered in Rockville, US.
Which VCs invest in companies like American Gene Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at American Gene Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like American Gene Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.